HIV Treatment Scale-Up and HIV-Related Stigma in Sub-Saharan Africa: A Longitudinal Cross-Country Analysis.

Autor: Chan BT; Brian T. Chan, Alexander C. Tsai, and Mark J. Siedner are with Harvard Medical School, Boston, MA. Brian T. Chan is also with the Brigham and Women's Hospital, Boston. Alexander C. Tsai and Mark J. Siedner are also with Massachusetts General Hospital, Boston., Tsai AC; Brian T. Chan, Alexander C. Tsai, and Mark J. Siedner are with Harvard Medical School, Boston, MA. Brian T. Chan is also with the Brigham and Women's Hospital, Boston. Alexander C. Tsai and Mark J. Siedner are also with Massachusetts General Hospital, Boston., Siedner MJ; Brian T. Chan, Alexander C. Tsai, and Mark J. Siedner are with Harvard Medical School, Boston, MA. Brian T. Chan is also with the Brigham and Women's Hospital, Boston. Alexander C. Tsai and Mark J. Siedner are also with Massachusetts General Hospital, Boston.
Jazyk: angličtina
Zdroj: American journal of public health [Am J Public Health] 2015 Aug; Vol. 105 (8), pp. 1581-7. Date of Electronic Publication: 2015 Jun 11.
DOI: 10.2105/AJPH.2015.302716
Abstrakt: Objectives: We estimated the association between antiretroviral therapy (ART) uptake and HIV-related stigma at the population level in sub-Saharan Africa.
Methods: We examined trends in HIV-related stigma and ART coverage in sub-Saharan Africa during 2003 to 2013 using longitudinal, population-based data on ART coverage from the Joint United Nations Program on HIV/AIDS and on HIV-related stigma from the Demographic and Health Surveys and AIDS Indicator Surveys. We fitted 2 linear regression models with country fixed effects, with the percentage of men or women reporting HIV-related stigma as the dependent variable and the percentage of people living with HIV on ART as the explanatory variable.
Results: Eighteen countries in sub-Saharan Africa were included in our analysis. For each 1% increase in ART coverage, we observed a statistically significant decrease in the percentage of women (b = -0.226; P = .007; 95% confidence interval [CI] = -0.383, -0.070) and men (b = -0.281; P = .009; 95% CI = -0.480, -0.082) in the general population reporting HIV-related stigma.
Conclusions: An important benefit of ART scale-up may be the diminution of HIV-related stigma in the general population.
Databáze: MEDLINE
Externí odkaz: